Skip to main content
. 2014 Jul 23;14:188. doi: 10.1186/1471-2431-14-188

Table 1.

Clinical features of the four infants with PNDM

  Case 1 Case 2 Case 3 Case 4
At diagnosis
Age
14 days
37 days
2 months
38 days
Gender
F
M
M
M
Family history of diabetes
negative
negative
negative
negative
Birth weight
AGA
AGA
AGA
AGA
Blood glucose level (mmol/L)
39.0
48.5
27.0
40.0
HbA1c (%)
5.9
8.3
11.9
8.5
C-peptide (ng/mL)
0.31
0.20
0.25
0.57
Insulin level (mIU/L)
3.1
1.5
0.9
No data
DKA
yes
yes
no
yes
ABG
pH
7.114
7.250
7.330
6.911
Bicarbonate (mmol/L)
5.2
16.9
25.6
4.5
Pancreatic autoantibody
negative
negative
negative
negative
Urine
Urine sugar
4+
4+
3+
4+
Urine ketone
4+
4+
+/-
3+
Pancreas ultrasonography
normal
normal
normal
normal
Recent follow-up
Age
35 months
45 months
54 months
60 months
Insulin injections
CSII
MII
MII
MII
Insulin dosage
Humulin: basal 0.6 U/kg/dbolus 0.2 U/kg/d
Humulin: 0.7 U/kg/ day
Novolin 30R: 0.4 U/kg/ day
Humulin: 0.5 U/kg/day
Hypoglycemia/hyperglycemia
rare
few
sometimes
always
HbA1c (%)
6.7
7.1
8.0
10.5
Combine with other problems Development delay No epilepsy No

PNDM, permanent neonatal diabetes mellitus; AGA, appropriate for gestational age; HbA1c, glycosylated hemoglobin; ABG, arterial blood gas; CSII, continuous subcutaneous insulin infusion; MII, multiple insulin injections; DKA, diabetic ketoacidosis.